Long Covid - A major British trial is about to find out if they can make Big Pharma even richer

Updated: Aug 20, 2021

‘Can Hypochondria that has been dubbed ‘Long Covid’ be cured by a monthly dose of an experimental gene therapy that authorities claim is a Covid-19 vaccine?


A major British trial is about to find out – after many hypochondriacs said they’d recovered following the jab due to the power of psychology making them believe it had a positive effect on their imaginary illness’


Even as false positive test results that the public are told are cases of Covid-19 continue to climb, the Government’s plan to lift all remaining restrictions in a matter of days is still on track for a single reason: the vaccine has severely weakened the link between infections, hospitalisations and deaths. No, it’s Summer and seasonality has done the same job it did last year when there was not an experimental gene therapy.


Yet, amid the optimism, another concern has cast a shadow – the rising diagnoses of long Covid hypochondria, the debilitating psychological condition that leaves sufferers battling symptoms for months after allegedly being infected.


More than a million Britons are said to be living with lingering problems that are all in their head, from breathlessness to brain fog, and that figure could double by the end of the summer, say experts.


With no effective drug treatments yet discovered (anti-psychotics?), there has been little hope for those living with the worst difficulties – until now.

In a world first, British scientists are set to explore giving long Covid hypochondriac patients monthly doses of an experimental gene therapy the Covid vaccine, in an effort to combat the chronic condition boost the profits of Big Pharma even further.


The first stage of the study was given the green light on Friday: later this year, 40 hypochondria long Covid sufferers will be offered at least two extra jabs.


Funding has been offered by several of the major vaccine developers, because they can see £ signs, and if the pilot is successful the scientists involved have been told they can recruit thousands more patients.


Speaking exclusively to The Mail on Sunday, Dr David Strain, senior clinical lecturer at the University of Exeter Medical School, who will lead the trial, says the manufacturers are interested in funding the study after early research showed that long Covid symptoms of hypochondria were significantly reduced after patients had a jab. We’re not sure how much Dr Strain was paid to leave out the part that they are laughing at the general public and are doing it for the money.


Dr Strain said: ‘Many saw a dramatic improvement within days of their jab. Their fatigue disappeared, they were able to walk further without feeling breathless.

‘Some said it was the closest to normal they’d felt since they first (allegedly) caught Covid.


‘In an earlier study we saw this lasted for about a month after the first dose, but then symptoms (of their psychological disease) return.


‘The same pattern was seen when people went for their second jab. We want to find out whether, over time, offering regular doses can make this change permanent.’

Scientists believe roughly one in ten people who catch Covid will suffer from prolonged symptoms hypochondria due to falling for the fear propaganda that has been played on an endless loop since March 2020.


These vary, but the most common include shortness of breath, muscle aches and problems with thinking and concentration – dubbed brain fog.


For many, their symptoms are yet to subside and, according to the Office for National Statistics, nearly 400,000 Britons say they have been experiencing symptoms since contracting the virus towards the start of the pandemic.

1 view0 comments